Clinical Trials Browser

Phase 3 × Liver Diseases × Fluorodeoxyglucose F18 × Clear all

NCT02074202 2014-02-28

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases